Avidity Biosciences SG&A Expenses 2019-2024 | RNA

Avidity Biosciences sg&a expenses for the twelve months ending September 30, 2024 were $0.074B, a 52.76% increase year-over-year.

  • Avidity Biosciences annual sg&a expenses for 2023 were $0.054B, a 43.61% increase from 2022.
  • Avidity Biosciences annual sg&a expenses for 2022 were $0.038B, a 44.05% increase from 2021.
  • Avidity Biosciences annual sg&a expenses for 2021 were $0.026B, a 94.58% increase from 2020.

Avidity Biosciences SG&A Expenses 2019-2024 | RNA

  • Avidity Biosciences annual sg&a expenses for 2023 were $0.054B, a 43.61% increase from 2022.
  • Avidity Biosciences annual sg&a expenses for 2022 were $0.038B, a 44.05% increase from 2021.
  • Avidity Biosciences annual sg&a expenses for 2021 were $0.026B, a 94.58% increase from 2020.